Page 1,412«..1020..1,4111,4121,4131,414..1,4201,430..»

Human Genetics – McGraw-Hill Education

Posted: November 18, 2018 at 4:44 pm

Introduction

C H A P T E R 1

What Is in a Human Genome?

C H A P T E R 2

Cells

C H A P T E R 3

Meiosis, Development, and Aging

P A R T 2

Transmission Genetics

C H A P T E R 4

Single-Gene Inheritance

C H A P T E R 5

Beyond Mendels Laws

C H A P T E R 6

Matters of Sex

C H A P T E R 7

Multifactorial Traits

C H A P T E R 8

Genetics of Behavior

P A R T 3

DNA and Chromosomes

C H A P T E R 9

DNA Structure and Replication

C H A P T E R 10

Gene Action: From DNA to Protein

C H A P T E R 11

Gene Expression and Epigenetics

C H A P T E R 12

Gene Mutation

C H A P T E R 13

Chromosomes

P A R T 4

Population Genetics

C H A P T E R 14

Constant Allele Frequencies and DNA Forensics

C H A P T E R 15

Changing Allele Frequencies

C H A P T E R 16

Human Ancestry and Evolution

P A R T 5

Immunity and Cancer

C H A P T E R 17

Genetics of Immunity

C H A P T E R 18

Cancer Genetics and Genomics

P A R T 6

Genetic Technology

C H A P T E R 19

DNA Technologies

C H A P T E R 20

Genetic Testing and Treatment

C H A P T E R 21

Reproductive Technologies

C H A P T E R 22

Genomics

See original here:
Human Genetics - McGraw-Hill Education

Posted in Human Genetics | Comments Off on Human Genetics – McGraw-Hill Education

Mitochondrial Eve – Wikipedia

Posted: November 18, 2018 at 4:44 pm

In human genetics, the Mitochondrial Eve (also mt-Eve, mt-MRCA) is the matrilineal most recent common ancestor (MRCA) of all currently living humans, i.e., the most recent woman from whom all living humans descend in an unbroken line purely through their mothers, and through the mothers of those mothers, back until all lines converge on one woman.

In terms of mitochondrial haplogroups, the mt-MRCA is situated at the divergence ofmacro-haplogroup L into L0and L16.As of 2013, estimates on the age of this split ranged at around 150,000 years ago,[2] consistent with a date later than the speciation of Homo sapiens but earlier than the recent Out-of-Africa dispersal.[3]

The male analog to the "Mitochondrial Eve" is the "Y-chromosomal Adam" (or Y-MRCA), the individual from whom all living humans are patrilineally descended. As the identity of both matrilineal and patrilineal MRCAs is dependent on genealogical history (pedigree collapse), they need not have lived at the same time.As of 2013, estimates for the age Y-MRCA are subject to substantial uncertainty, with a wide range of times from 180,000 to 580,000 years ago[4][5][6] (with an estimated age of between 120,000 and 156,000 years ago, roughly consistent with the estimate for mt-MRCA.).[7][8]

The name "Mitochondrial Eve" alludes to biblical Eve. This led to repeated misrepresentations or misconceptions in journalistic accounts on the topic. Popular science presentations of the topic usually point out such possible misconceptions by emphasizing the fact that the position of mt-MRCA is neither fixed in time (as the position of mt-MRCA moves forward in time as mtDNA lineages become extinct), nor does it refer to a "first woman", nor the only living female of her time, nor the first member of a "new species".[9]

-10

-9

-8

-7

-6

-5

-4

-3

-2

-1

0

Early research using molecular clock methods was done during the late 1970s to early 1980s.Allan Wilson, Mark Stoneking, Rebecca L. Cann and Wesley M. Brown found that mutation in human mtDNA was unexpectedly fast, at 0.02 substitution per base (1%) in a million years, which is 510 times faster than in nuclear DNA.[10]Related work allowed for an analysis of the evolutionary relationships among gorillas, chimpanzees (common chimpanzee and bonobo) and humans.[11]With data from 21 human individuals, Brown published the first estimate on the age of the mt-MRCA at 180,000 years ago in 1980.[12]A statistical analysis published in 1982 was taken as evidence for recent African origin (a hypothesis which at the time was competing with Asian origin of H. sapiens).[13]

By 1985, data from the mtDNA of 145 women of different populations, and of two cell lines, HeLa and GM 3043, derived from a Black American and a !Kung respectively, was available. After more than 40 revisions of the draft, the manuscript was submitted to Nature in late 1985 or early 1986[14] and published on 1 January 1987. The published conclusion was that all current human mtDNA originated from a single population from Africa, at the time dated to between 140,000 and 200,000 years ago.[15]

The dating for "Eve" was a blow to the multiregional hypothesis, which was being controversially discussed at the time, and a boost to the theory of the recent origin model.[16]

Cann, Stoneking and Wilson did not use the term "Mitochondrial Eve" or even the name "Eve" in their original paper; it appears to originate with a 1987 article in Science by Roger Lewin, headlined "The Unmasking of Mitochondrial Eve."[17]The biblical connotation was very clear from the start. The accompanying research news in Nature had the title "Out of the garden of Eden."[18] Wilson himself preferred the term "Lucky Mother" [19] and thought the use of the name Eve "regrettable."[17][20]But the concept of Eve caught on with the public and was repeated in a Newsweek cover story (11 January 1988 issue featured a depiction of Adam and Eve on the cover, with the title "The Search for Adam and Eve"),[21] and a cover story in Time on 26 January 1987.[22]

Shortly after the 1987 publication, criticism of its methodology and secondary conclusions was published.[23]Both the dating of mt-Eve and the relevance of the age of the purely matrilineal descent for population replacement was controversially discussed during the 1990s;[24][25][26][27]Alan Templeton (1997) asserted that the study did "not support the hypothesis of a recent African origin for all of humanity following a split between Africans and non-Africans 100,000 years ago" and also did "not support the hypothesis of a recent global replacement of humans coming out of Africa."[28]

Cann, Stoneking & Wilson (1987)'s placement of a relatively small population of humans in sub-Saharan Africa was consistent with the hypothesis of Cann (1982) and lent considerable support for the "recent out-of-Africa" scenario.

In 1999 Krings et al. eliminated problems in molecular clocking postulated by Nei (1992)[citation needed] when it was found that the mtDNA sequence for the same region was substantially different from the MRCA relative to any human sequence.

Although the original research did have analytical limitations, the estimate on the age of the mt-MRCA has proven robust.[29][30] More recent age estimates have remained consistent with the 140200 kya estimate published in 1987: A 2013 estimate dated Mitochondrial Eve to about 160 kya (within the reserved estimate of the original research) and Out of Africa II to about 95 kya.[31]Another 2013 study (based on genome sequencing of 69 people from 9 different populations) reported the age of Mitochondrial Eve between 99 to 148 kya and that of the Y-MRCA between 120 and 156 kya.[7]

Without a DNA sample, it is not possible to reconstruct the complete genetic makeup (genome) of any individual who died very long ago. By analysing descendants' DNA, however, parts of ancestral genomes are estimated by scientists. Mitochondrial DNA (mtDNA) and Y-chromosome DNA are commonly used to trace ancestry in this manner. mtDNA is generally passed un-mixed from mothers to children of both sexes, along the maternal line, or matrilineally.[32][33] Matrilineal descent goes back to our mothers, to their mothers, until all female lineages converge.

Branches are identified by one or more unique markers which give a mitochondrial "DNA signature" or "haplotype" (e.g. the CRS is a haplotype). Each marker is a DNA base-pair that has resulted from an SNP mutation. Scientists sort mitochondrial DNA results into more or less related groups, with more or less recent common ancestors. This leads to the construction of a DNA family tree where the branches are in biological terms clades, and the common ancestors such as Mitochondrial Eve sit at branching points in this tree. Major branches are said to define a haplogroup (e.g. CRS belongs to haplogroup H), and large branches containing several haplogroups are called "macro-haplogroups".

The mitochondrial clade which Mitochondrial Eve defines is the species Homo sapiens sapiens itself, or at least the current population or "chronospecies" as it exists today. In principle, earlier Eves can also be defined going beyond the species, for example one who is ancestral to both modern humanity and Neanderthals, or, further back, an "Eve" ancestral to all members of genus Homo and chimpanzees in genus Pan. According to current nomenclature,Mitochondrial Eve's haplogroup was within mitochondrial haplogroup L because this macro-haplogroup contains all surviving human mitochondrial lineages today, and she must predate the emergence of L0.

The variation of mitochondrial DNA between different people can be used to estimate the time back to a common ancestor, such as Mitochondrial Eve. This works because, along any particular line of descent, mitochondrial DNA accumulates mutations at the rate of approximately one every 3,500 years per nucleotide.[34][35][36] A certain number of these new variants will survive into modern times and be identifiable as distinct lineages. At the same time some branches, including even very old ones, come to an end, when the last family in a distinct branch has no daughters.

Mitochondrial Eve is the most recent common matrilineal ancestor for all modern humans. Whenever one of the two most ancient branch lines dies out, the MRCA will move to a more recent female ancestor, always the most recent mother to have more than one daughter with living maternal line descendants alive today. The number of mutations that can be found distinguishing modern people is determined by two criteria: firstly and most obviously, the time back to her, but secondly and less obviously by the varying rates at which new branches have come into existence and old branches have become extinct. By looking at the number of mutations which have been accumulated in different branches of this family tree, and looking at which geographical regions have the widest range of least related branches, the region where Eve lived can be proposed.

Newsweek reported on Mitochondrial Eve based on the Cann et al. study in January 1988, under a heading of "Scientists Explore a Controversial Theory About Man's Origins". The edition sold a record number of copies.[37]

The popular name "mitochondrial Eve", of 1980s coinage,[17] has contributed to a number of popular misconceptions. At first, the announcement of a "mitochondrial Eve" was even greeted with endorsement from young earth creationists, who viewed the theory as a validation of the biblical creation story.[38]

Due to such misunderstandings, authors of popular science publications since the 1990s have been emphatic in pointing out that the name is merely a popular convention, and that the mt-MRCA was not in any way the "first woman".[39] Her position is purely the result of genealogical history of human populations later, and as matrilineal lineages die out, the position of mt-MRCA keeps moving forward to younger individuals over time.

In River Out of Eden (1995), Richard Dawkins discussed human ancestry in the context of a "river of genes", including an explanation of the concept of Mitochondrial Eve.[40]The Seven Daughters of Eve (2002) presented the topic of human mitochondrial genetics to a general audience.[41]The Real Eve: Modern Man's Journey Out of Africa" by Stephen Oppenheimer (2003)[42] was adapted into a Discovery Channel documentary.[43]

One common misconception surrounding mitochondrial Eve is that since all women alive today descended in a direct unbroken female line from her, she must have been the only woman alive at the time.[39][44] However, nuclear DNA studies indicate that the size of the ancient human population never dropped below tens of thousands. Other women living during Eve's time may have descendants alive today but not in a direct female line.[citation needed]

The definition of mitochondrial Eve is fixed, but the woman in prehistory who fits this definition can change. That is, not only can our knowledge of when and where Mitochondrial Eve lived change due to new discoveries, but the actual mitochondrial Eve can change. The mitochondrial Eve can change, when a mother-daughter line comes to an end by chance. It follows from the definition of Mitochondrial Eve that she had at least two daughters who both have unbroken female lineages that have survived to the present day. In every generation mitochondrial lineages end when a woman with unique mtDNA dies with no daughters. When the mitochondrial lineages of daughters of mitochondrial Eve die out, then the title of "Mitochondrial Eve" shifts forward from the remaining daughter through her matrilineal descendants, until the first descendant is reached who had two or more daughters who together have all living humans as their matrilineal descendants. Once a lineage has died out it is irretrievably lost and this mechanism can thus only shift the title of "Mitochondrial Eve" forward in time.

Because mtDNA mapping of humans is very incomplete, the discovery of living mtDNA lines which predate our current concept of "Mitochondrial Eve" could result in the title moving to an earlier woman. This happened to her male counterpart, "Y-chromosomal Adam," when older Y lines from Africa were discovered.

Sometimes mitochondrial Eve is assumed to have lived at the same time as Y-chromosomal Adam (from whom all living people are descended patrilineally), and perhaps even met and mated with him. Even if this were true, which is currently regarded as highly unlikely, this would only be a coincidence. Like mitochondrial "Eve", Y-chromosomal "Adam" probably lived in Africa. A recent study (March 2013) concluded however that "Eve" lived much later than "Adam" some 140,000 years later.[5] (Earlier studies considered, conversely, that "Eve" lived earlier than "Adam".)[45] More recent studies indicate that mitochondrial Eve and Y-chromosomal Adam may indeed have lived around the same time.[46]

Mitochondrial Eve is the most recent common matrilineal ancestor, not the most recent common ancestor. Since the mtDNA is inherited maternally and recombination is either rare or absent, it is relatively easy to track the ancestry of the lineages back to a MRCA; however, this MRCA is valid only when discussing mitochondrial DNA. An approximate sequence from newest to oldest can list various important points in the ancestry of modern human populations:

View post:
Mitochondrial Eve - Wikipedia

Posted in Human Genetics | Comments Off on Mitochondrial Eve – Wikipedia

Genetic Medicine – University of Chicago – Department of …

Posted: November 18, 2018 at 4:44 pm

Yoav Gilad, PhD

Chief, Section of Genetic Medicine

University of ChicagoDepartment of Medicine

The Section of Genetic Medicine was created over 10 years ago to both build research infrastructure in genetics within the Department of Medicine and to focus translational efforts related to genetics. As a result, the Section of Genetic Medicine is shaping the future of precision medicine with very active and successful research programs focused on the quantitative genetics, systems biology and genomics, and bioinformatics and computational biology. The Section provides extremely valuable collaborations with investigators in the Department of Medicine who are seeking to develop new and more powerful ways to identify genetic risk factors for common, complex disorders with almost immediate clinical application.

The Section of Genetic Medicine continues to shape the future of personalized medicine with successful research programs focused on the quantitative genetic and genomic science. The Section provides extremely valuable collaborations with investigators in the Department of Medicine who are seeking to develop new and more powerful ways to identify genetic risk factors for common, complex disorders with almost immediate clinical application.

The Section of Genetic Medicine conducts impactful investigations focused on quantitative genetics, systems biology and genomics, bioinformatics and computational biology. Some highlights from the past year include:

Read more here:
Genetic Medicine - University of Chicago - Department of ...

Posted in Genetic medicine | Comments Off on Genetic Medicine – University of Chicago – Department of …

Genetic Medicine | Internal Medicine | Michigan Medicine …

Posted: November 18, 2018 at 4:44 pm

Goutham Narla, MD, PhD, Chief, Division of Genetic Medicine

As use of genomic technologies continue to increase in research and clinical settings, the Division of Genetic Medicine serves a key role in bringing together basic, clinical, and translational expertise in genomic medicine, with multidisciplinary faculty comprised of MDs, PhD scientists, and genetic counselors. Demand for expertise in genetics continues to increase, and the Division of Genetic Medicine is committed to advancing scientific discovery and clinical care of patients.

In addition to our Medical Genetics Clinic, genetics services are available through several other Michigan Medicine clinics and programs, including the Breast and Ovarian Cancer Risk Evaluation Program, Cancer GeneticsClinic,Inherited Cardiomyopathies and Arrhythmias Program,Neurogenetics Clinic, Pediatric Genetics Clinic, and Prenatal Evaluation Clinic.

Our faculty are focused on various research areas including cancer genetics, inherited hematologic disorders, neural stem cells,the mechanisms and regulation of DNA repair processes in mammalian cells, predictive genetic testing,understanding the mechanisms controlled by Hox genes, birth defects, bleeding and thrombotic disorders, and human limb malformations.

Division of Genetic Medicinefaculty are actively engaged in the education, teaching, and mentorship of clinicians, and clinical and basic scientists, including undergraduate and graduate students, medical students, residents, and fellows from various subspecialties.

Originally posted here:
Genetic Medicine | Internal Medicine | Michigan Medicine ...

Posted in Genetic medicine | Comments Off on Genetic Medicine | Internal Medicine | Michigan Medicine …

Pittsburgh, Pennsylvania – Stem Cells Transplant Institute

Posted: November 18, 2018 at 4:42 pm

One of the next big leaps in biomedical science and engineering is likely to come when more secrets are revealed about the workings of stem cells. Currently, stem cells investigation is growing fast and the outcomes have been very promising. Most cities in the United States including Pittsburgh are still in clinical trial phase, close to legally approved therapies.

Pittsburgh is the second largest city in Pennsylvania. Since the collapse of many industries, Pittsburgh has adapted its economy. The region has shifted to high technology, robotics, health care, nuclear engineering, tourism, biomedical technology, finance, education and services. Stem cells research is definitely part of the citys target points.

As some examples of how Pittsburgh is involved in the stem cells world, the University of Pittsburg has The Adipose Stem Cells Research Laboratory, which consists of 1200 square feet of space in the Biomedical Science Tower; directed by Kacey G. Marra, PhD. This laboratory conducts scientific investigation in multiple interdisciplinary areas. Novel biomaterials are being designed for soft tissue, skin and nerve regeneration. This laboratory isolates adult stem cells from human adipose tissue, and is exploring applications of these cells in soft tissue reconstruction.

On the other hand, the Center for Cellular and Molecular Engineering at the Pittsburgh University is employing adult mesenchymal stem cells from a variety of sources including bone marrow, trabecular bone, adipose tissue, umbilical cord and dental pulp to engineer a variety of tissues. The number and utility of the cells varies with the source. Adult mesenchymal stem cells are easily obtainable, have a broad capacity for stable differentiation, and contribute to wound healing and graft acceptance through their tropic and immunomodulatory effects.

Advancements in autologous stem cell treatment are giving patients from Norwin, Gladwyne, Fox Chapel, Sewickley Heights and Edgeworth the ability to fight back against diseases once thought untreatable. Stem Cells Transplant Institute in Costa Rica takes the most advanced and effective elements of Stem Cell Therapy and Regenerative Medicine, and combines them with the best environment to recover.Apply now.

The Stem Cells Transplant Institute of Costa Rica specializes in the legal treatment of Rheumatoid Arthritis, Diabetes, COPD, Knee Injury, Multiple Sclerosis, Lupus, Alzheimer, Cardiovascular Disease, Parkinson, Osteoarthritis, Erectile Dysfunction, Myocardial infarction, Neuropathy and Critical limb isquemia.Contact us.

Your journey to wellness begins here at Stem Cells Transplant Institute in Costa Rica, with a wide knowledge and understanding of adult stem cell therapy. At Stem Cell Transplant Institute in Costa Rica, we provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. Dont miss what you enjoy the most! Watch your favorite games of Pittsburgh Pirates, Pittsburgh Steelers and Pittsburgh Penguins with no pain!!!! Get more information about legally approved stem cell therapies now.

Go here to read the rest:
Pittsburgh, Pennsylvania - Stem Cells Transplant Institute

Posted in Pennsylvania Stem Cells | Comments Off on Pittsburgh, Pennsylvania – Stem Cells Transplant Institute

Dallas, Texas, Stem Cells Treatment, Legal, Ft. Worth …

Posted: November 16, 2018 at 8:43 am

There are very encouraging news for the field of stem cell research and especially for patients from Dallas with established disability as a result of stroke, diabetes, degenerative or inflammatory diseases where this is no proven treatment to aid recovery. Stem cell therapies are being already used all over the world with great outcomes; however, stem cells treatment is not legally approved in most clinics in Dallas and other cities in the United States.

Residents from Fort Worth, West University, University Park, Southlake, San Antonio, Highland Park, Bellaire and Colleyville, can now access one the most revolutionary treatments today. Contact us.

Costa Rica is one of the to destinies in medical tourism, due to its excellent healthcare systems and to its extraordinary natural resources, which makes Costa Rica your best choice to access legally approved therapies and save some money.

The Stem Cells Transplant Institute of Costa Rica specializes in the legal treatment of Parkinson, Cardiovascular Disease, Knee Injury, Multiple Sclerosis, Diabetes, Lupus, Osteoarthritis, Rheumatoid Arthritis, Critical limb isquemia, Erectile Dysfunction, Chronic Obstructive pulmonary disease, Alzheimer, Myocardial infarction and Neuropathy.Contact us.

At Stem Cells Transplant Institute in Costa Rica we believe that through these new, world-class therapies; our patients from Dallas will have significant benefits. We want you to access stem cells therapies with highest standards of quality in health care and values. Apply now.

Read more here:
Dallas, Texas, Stem Cells Treatment, Legal, Ft. Worth ...

Posted in Texas Stem Cells | Comments Off on Dallas, Texas, Stem Cells Treatment, Legal, Ft. Worth …

Stem Cell Therapy | Advanced Regenerative Orthopedics

Posted: November 14, 2018 at 11:41 pm

Stem Cell Therapy involves the use of stem cells to stimulate the bodys natural repair mechanisms to repair, regenerate or replace damaged cells, tissues and organs. This physician-directed therapy is very safe, ethical and does not entail the use of any fetal or embryonic cells or tissue. It has been described as the future of medicine by many prestigious groups including the National Institutes of Health and the Institute of Medicine.

The field of Stem Cell Therapy continues to evolve, focusing on cures rather than just treatments for essentially all types of chronic diseases and conditions, including diabetes and cardiovascular disease, as well as various forms of arthritis and various orthopedic problems. When cells are transplanted into a patient, they do not stay for more than a few days. However, the cells provide a large and robust stimulus to turn on native repair mechanisms. The number of stem cells present in the body and their functional capacity to repair damaged tissue declines with each advancing decade of life, and chronic diseases further impede their ability to respond to chronic injury or damage in the body. This is why research has led to new solutions, which include the use of umbilical cord blood as the source of cells, which have the most potent ability to generate new tissues without risk of rejection. We at Advanced Regenerative Orthopedics use stem cells that are supplied by an FDA-registered cord blood bank.

Stem Cell Therapy and Tissue Engineering are much simpler and effective options that use very powerful young cells to stimulate the patients own native repair mechanisms to regenerate new cartilage and bone. The physician-directed treatment at ARO is a comprehensive approach to a specific joint with the goal of reducing the disabling pain and increasing function.

At Advanced Regenerative Orthopedics, our goal is to provide minimally invasive treatments along with regenerative techniques to target your bodys natural healing ability. Used as part of our innovative, three-tiered approach, physician-directed arthritis stem cell treatment can help patients of all ages get pain relief, increase their joint mobility and enjoy a higher quality of life.

Stem cell therapy can be an effective treatment for those suffering from a broad range of arthritic conditions. By using stem cells for arthritis, Advanced Regenerative Orthopedics stimulates your bodys natural mechanism to repair, regenerate and replace damaged cells within your joints.

If you live in Tampa, Brandon, St. Petersburg, Clearwater, Lakeland, Sarasota, The Villages, Ocala, or the surrounding areas and are interested in learning more about using stem cells for arthritis or any other joint condition, please contact our courteous and efficient office staff today to schedule an appointment. We look forward to discussing the benefits of physician-directed arthritis stem cell treatment with you and determining the best course of treatment to restore your joint health.

As many of our patients travel to us from outside the state of Florida for our world class procedures, our team is very familiar with managing the care & travel for remote patients.

Read the rest here:
Stem Cell Therapy | Advanced Regenerative Orthopedics

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy | Advanced Regenerative Orthopedics

Stem Cell Therapy for Heart Disease | Cleveland Clinic

Posted: November 14, 2018 at 11:41 pm

Stem Cell Therapy: Helping the Body Heal Itself

Stem cells are natures own transformers. When the body is injured, stem cells travel the scene of the accident. Some come from the bone marrow, a modest number of others, from the heart itself. Additionally, theyre not all the same. There, they may help heal damaged tissue. They do this by secreting local hormones to rescue damaged heart cells and occasionally turning into heart muscle cells themselves. Stem cells do a fairly good job. But they could do better for some reason, the heart stops signaling for heart cells after only a week or so after the damage has occurred, leaving the repair job mostly undone. The partially repaired tissue becomes a burden to the heart, forcing it to work harder and less efficiently, leading to heart failure.

Initial research used a patients own stem cells, derived from the bone marrow, mainly because they were readily available and had worked in animal studies. Careful study revealed only a very modest benefit, so researchers have moved on to evaluate more promising approaches, including:

No matter what you may read, stem cell therapy for damaged hearts has yet to be proven fully safe and beneficial. It is important to know that many patients are not receiving the most current and optimal therapies available for their heart failure. If you have heart failure, and wondering about treatment options, an evaluation or a second opinion at a Center of Excellence can be worthwhile.

Randomized clinical trials evaluating these different approaches typically allow enrollment of only a few patients from each hospital, and hence what may be available at the Cleveland Clinic varies from time to time.

Reviewed: 08/17

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Excerpt from:
Stem Cell Therapy for Heart Disease | Cleveland Clinic

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy for Heart Disease | Cleveland Clinic

Stem Cell Therapy for Knees: Definitive Guide [with Patient …

Posted: November 14, 2018 at 11:41 pm

The stem cell procedure for the treatment of knee pain is minimally invasive, takes about 3 hours, and patients walk out of the office on their own following treatment. To start, stem cells are harvested from your abdominal or love handle fat using high tech, minimally-invasive liposuction equipment. Stem cells from your bone marrow are also utilized. The bone marrow concentrate is harvested using a specially designed, low-trauma needle which is placed into the posterior iliac crest under live x-ray guidance.

Mild IV sedation, in combination with local anesthetic, is used to provide patient comfort during the procedure. The harvested cells are then prepared for injection using an advanced separation and centrifugation process.

With the use of live x-ray guidance, the cells and growth factors are injected into the affected knee joint under sterile conditions. Dr. Brandts extensive experience with knee injections, along with the aid of the appropriate image guidance, ensures the cells are reaching their targeted area so you have the best chance for improvement.

To complement the high stem cell count achieved with the use of adipose derived stem cells, we often utilize PRP, A2M, and placental derived growth factors during our knee procedures and follow-up treatments.

See the article here:
Stem Cell Therapy for Knees: Definitive Guide [with Patient ...

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy for Knees: Definitive Guide [with Patient …

#1 Guide To Stem Cell Therapy For Hair Loss In 2018

Posted: November 14, 2018 at 11:41 pm

Stem cell therapy may be the key to curing hair loss forever. But the technology is still in development.

In this article Ill look at how stem cell therapy works to restore lost hair. Ill help you decide if it could be a good option for you

And youll also find out how long you might have to wait before the treatment is available.

Advances in the understanding of stem cell biology may offer potential treatments for a variety of conditions, including hair loss, receding hairlines, and thinning hair.

While the research involving stem cells has been hampered by political influence in the past, there have been many recent advancements in the science of stem cell therapy and calls for further research.

Stem cell research holds promise for addressing a wide array of human malady, and some of the current research focuses on treating skin conditions and other causes of hair loss.

In basic terms, a stem cell is an undifferentiated cell that has the potential to develop into different types of cells within the body. According the the National Institutes of Health, stem cells also serve as a type of internal repair system for many tissues.

These cells have an almost limitless capacity to divide as long as the organism is alive, replenishing other cells indefinitely as cells grow through normal cycles of death and regeneration.

When a stem cell divides into two cells, each of these cells has the ability to remain a stem cell or become another type of more specialized cell such as epithelial or blood cells.

Currently, stem cells are divided into two sub-groups based on their origin, and are either embryonic or adult derived.

While the research being done on the potential for stem cell therapies to address spans a significant range, stem cell therapy does show promise for treating a variety of conditions including hair loss.

While the research being done on the potential for stem cell therapies to address spans a significant range, stem cell therapy does show promise for treating a variety of conditions including hair loss.

However, there remains a lack of detail knowledge and research related to the specific potential of stem cell biology and the development of stem cell therapies.

The Journals of Gerontology have published articles related on stem cell biology, and discussed the role of stem cells in the process of hair growth and how stem cell biology can be related to hair loss.

The authors acknowledge the role of stem cells in the maintenance and growth of bodily cells, including those related to hair growth.

One potential cause of hair loss and thinning hair may be related to a condition known as stem cell exhaustion, which can occur for many reasons including genetic diseases.

There is initial research in potential treatments for stem cell exhaustion, the prevention of which can help to stop related hair loss.

In a groundbreaking article published in Nature, the authors discuss the role of stem cells in hair growth and their research towards utilizing stem cell therapies to treat conditions of hair loss.

In order for hair growth to take place, the hair follicle requires epithelial stem cells for the propagation of growth.

Until recently, the process of developing stems cells that are differentiated into epithelial cells has not been possible.

One of the most promising treatments utilizing stem cell therapy comes from research out of China and Canada, where scientists have successfully been able to re-seed hairlines with epithelial stem cells.

Traditional treatments utilizing medication, or even hair follicle transplants, may work for a period of time but continued growth at the follicle has proven difficult to sustain.

These treatments are also unable to continuously regenerate new hair follicles once the treatment has ended.

The current studies on rodents provide some promise that some of the prior difficulties in using stem cells may have been solved through the use of a layer of dermal papilla cells that serve as a protective layer for the initial seeding process.

This coating has improved the therapeutic effect of the stem cell therapy, allowing the hair follicle to continue the normal process of morphogenesis and hair cycling.

Research from the University of Pennsylvania, funded by the US National Institutes of Health, has shown that converting stem cells that have not been differentiated into epithelial stem cells and injecting them into the skin of rodents will lead to the growth of human-like hair.

There remain some limitations to this treatment, including the fact that it has not yet been tested on human subject and that the growth that is seen does not include the sebaceous cells which are normally present in the growth of skin and epithelial cells.

The researchers also noted that some of the growth that took place were more representative of abnormal tumor-like lumps which would not be considered acceptable for treatment of hair loss or baldness in humans.

One study published in the US National Library of Medicine found that the number of hairs present in both males and females who received the treatment were significantly increased.

The same individual was treated on only half of their head, to provide a comparison, and it was found that the treatment side showed statistically significant improvements in the number of hairs.

The specific stem cells that were utilized are called adipose-derived stem cells.

While many of the potential treatments using stem cell therapy have only been tested on rodents, there remains promise in the continued and ongoing research that may address conditions of hair loss, receding hairlines, and thinning hair.

The most exciting aspect of stem cell therapies used to combat hair loss is that this type of treatment offers more long term solutions than hair transplants and has less potential for side effects than treatments involving medication or supplements.

Due to the relatively recent development of stem cell therapies, there remain a significant amount of unknowns about the potential treatments as well as the potential side effects.

The intention of stem cell therapies for treating hair loss is to encourage the growth and generation of epithelial cells, which are necessary for hair growth. However, one of the potential side effects according to a leader in stem cell research is that stem cell treatments can lead to the growth of benign tumors.

The goal is to induce cellular generation, but it can be difficult to ensure the generation of cells is isolated to the growth of hair. Another side effect that has been identified among researchers is that individuals undergoing a form of stem cell therapy commonly have aa weakened immune system

While scientists and researchers have known about the potential of stem cells for decades, the use of stem cell therapies has been somewhat controversial due to where stem cells can be obtained from.

According to the US Department of Health & Human Services, scientists have been utilizing two types of stem cells for research.

The two types of stem cells are embryonic stem cells or somatic/adult stem cells. The cultivation of human embryonic stem cells became controversial due to the nature of their propagation, and the types of research allowed became subject to significant limitations.

Recent advancements in stem cell research have allowed scientists to use the less controversial somatic/adult stem cells in areas of research and potential therapeutic options.

These advancements have made stem cell therapy significantly less controversial and opened up significant possibilities for the future of stem cell research and stem cell therapy.

There is still a significant amount of research to be done on the potential of stem cell therapy, however there are treatments available utilizing stem cells.

Unlike transplants of the past, hair stem cell transplantation utilizes an individuals own naturally developed hair follicles and adult derived stem cells to promote growth in an area where the hair has thinned or receded.

The area from which the follicles are harvested are not damaged and new hair growth will continue, and the area to which the follicles and adult derived stem cells are implanted will begin full hair growth in a matter of weeks.

This process is virtually painless, has limited potential for side effects, and does is not controversial due to the fact that the adult derived stem cells are obtained from the individual themselves.

There are currently limited options for stem cell therapies to address issues of hair loss, thinning hair, and receding hairlines. However, much of the current research being done shows significant promise for the further development of stem cell therapies that will be able to better address such issues.

One of the most intriguing aspects of the use of stem cell therapies for issues of hair loss is that these types of treatments may be able to address many of the underlying conditions that cause hair loss.

The future of stem cell therapies to treat baldness that occurs for a variety of underlying reasons is quite bright, and while the current treatments are in their infancy the potential held in stem cell research is quite promising.

See the article here:
#1 Guide To Stem Cell Therapy For Hair Loss In 2018

Posted in Stem Cell Therapy | Comments Off on #1 Guide To Stem Cell Therapy For Hair Loss In 2018

Page 1,412«..1020..1,4111,4121,4131,414..1,4201,430..»